Setting COVID-19 drug trials up for success

(Kyoto University) Clinical studies on drug candidates for COVID-19 may generate more robust results by ensuring randomization, early patient recruitment and treatment initiation, a new model shows.

https://www.eurekalert.org/pub_releases/2021-07/ku-scd062521.php

Source: EurekAlert! - Infectious and Emerging Diseases - July 6, 2021 Category: Infectious Diseases Source Type: news

More News: COVID-19 | Infectious Diseases | Study